Patent · US Active

Anti-MIF immunohistochemistry

US11402388B2 · kind B2 · utility

0Cited by

4References

15Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Michael Thiele · Wien, AT
Randolf Kerschbaumer · Klosterneuburg, AT
Dirk Voelkel · Weinheim, DE
Patrice Douillard · Wien, AT
Friedrich Scheiflinger · Wien, AT
Alexander SCHINAGL · Wien, AT

Key dates

Filing date	Jul 9, 2013
Grant date	Aug 2, 2022
Priority date	—
Expiry date	Jul 9, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N1/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention pertains to the specific detection of MIF, in particular oxMIF, in tissues. A detection method is provided which uses immunohistochemistry and wherein specific anti-oxMIF antibodies are used.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.